NULL
Rhode Island

Office of Generic Drugs (OGD/FDA) Awards $1M FDA Contract to CUBRC and EpiVax for Demonstration and Validation of Immunogenicity Risk Assessment Methods for Generic Peptide Drugs and Their Impurities

PROVIDENCE, , Oct. 2, 2018 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announced today that they have been awarded a two-year $1 million contract from the Food and Drug…
Continue Reading »
Rhode Island

SilverScript Insurance Company, a CVS Health Company, Introduces Three Medicare Prescription Drug Plan Options for 2019

WOONSOCKET, , Oct. 1, 2018 /PRNewswire/ -- SilverScript Insurance Company, a CVS Health (NYSE: CVS) company, today announced its new Medicare Prescription Drug Plan (PDP) options for 2019. Medicare beneficiaries in…
Continue Reading »
Rhode Island

ASTHO Launches National Campaign To Support Healthy Communities, Aligning With NACCHO And The U.S. Surgeon General

ARLINGTON, Va., Sept. 27, 2018 /PRNewswire/ -- The Association of State and Territorial Health Officials (ASTHO) announced this week the launch of a multi-year initiative to build healthier and more resilient…
Continue Reading »
Rhode Island

Teamsters Local 251 Principal Officer Matt Taibi Statement Regarding The Providence First Student Strike

EAST PROVIDENCE, , Sept. 21, 2018 /PRNewswire/ -- The following is the official statement from Teamsters Local 251 Principal Officer and Secretary-Treasurer Matt Taibi on the Providence First Student Strike. "In…
Continue Reading »